Clinical trials
Terminated Hepatitis C trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
127 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 4 |
| 2003 | 1 |
| 2004 | 6 |
| 2005 | 4 |
| 2006 | 7 |
| 2007 | 3 |
| 2008 | 9 |
| 2009 | 8 |
| 2010 | 7 |
| 2011 | 10 |
| 2012 | 13 |
| 2013 | 9 |
| 2014 | 5 |
| 2015 | 11 |
| 2016 | 4 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 127 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 9 |
| Gilead Sciences | 5 |
| Massachusetts General Hospital | 5 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 5 |
| Novartis Pharmaceuticals | 4 |
| Vertex Pharmaceuticals Incorporated | 4 |
| GlaxoSmithKline | 3 |
| Rockefeller University | 3 |
| University of Texas Southwestern Medical Center | 3 |
| Weill Medical College of Cornell University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 127 |
| Hepatitis C, Chronic | 25 |
| HIV Infections | 9 |
| Hepatitis | 8 |
| Fibrosis | 7 |
| Hepatitis B | 7 |
| Liver Diseases | 7 |
| Acquired Immunodeficiency Syndrome | 6 |
| Carcinoma, Hepatocellular | 5 |
| Liver Cirrhosis | 4 |
Trials
Showing 51 to 75 of 127. Each trial links to its page on Pharma Observatory.
27 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.